Free delivery over $100 Learn more

30 days return period Learn more

SKU: 0856ATC

KY821 Human Peripheral Blood Leukemia Immune Cells


Tumor Cell Lines > Leukemia Cell Lines

Product Type: Human Leukemia Cell Lines

Species: Human

Cell Type: Immune Cells

Source Organ: Blood


Regular price $1,249.00

Size

Care information

Display general product information or specific product information using metafields.

Delivery and Shipping

Add some general information about your delivery and shipping policies.

Cell Name: KY821

Leukemia cells. Dt=27-37 hr.

  • Description
    KY821 is a human acute myelomonocytic leukemia cell line derived from peripheral blood of a 28-year old male. The cells exhibit lymphocyte-like morphology and suspension culture properties, the cell may grow slowly at first after thawing. KY821 cells are characterized by its granulocytic maturation numerous double minute chromosomes (dmin) derived from chromosome 8, and the 8q22–24 containing MYC is amplified in dmin. KY821 cells also carry concurrent oncogenic NRAS and TP53R175H/- mutations, and these AML cells are matained by sustained expression of mutant p53. The fore-mentioned properties make KY821 and its clone cell line suitable for studying drug resistance mechanism and its relation with dmin. The cells are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast and Bacteria.
  • Product Name
    KY821
  • Product Type
    Human Leukemia Cell Lines
  • Species
    Human
  • Cell Type
    Lymphocyte-like
  • Source Organ
    Peripheral Blood
  • Disease
    Acute Myeloid Leukemia
  • Product Type
    Human Leukemia Cell Lines
  • Growth Conditions
    37 °C, 5% CO2
  • Application
    The KY821 cell line is used in AML pathogenisis research, drug screening and resistance studies. These studies are closely associatedwith its molecular mechanisms underlying hematopoietic neoplasms. In the durg preclinical screening, the KY821 show different responses and effects to each drug due to its multiple hematopoietic growth factors. Thus KY821 would be an ideal model for drug comparative studies, enable the identification of more precise resistant clone.
  • Size/Quantity
    1 vial
  • Recommended Medium And Supplement

    RPMI 1640 + 10% FBS
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen
  • Biosafety Level
    1

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.